Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1960 1
1961 1
1962 1
1972 1
1973 1
1974 1
1976 2
1977 2
1979 5
1980 3
1981 1
1982 1
1983 3
1984 1
1985 4
1986 6
1987 4
1988 8
1989 13
1990 12
1991 6
1992 15
1993 13
1994 17
1995 16
1996 23
1997 20
1998 23
1999 38
2000 39
2001 37
2002 28
2003 38
2004 34
2005 26
2006 14
2007 20
2008 18
2009 18
2010 16
2011 21
2012 7
2013 15
2014 19
2015 21
2016 16
2017 14
2018 14
2019 32
2020 46
2021 39
2022 43
2023 30
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

802 results

Results by year

Filters applied: . Clear all
Page 1
Irinotecan: 25 years of cancer treatment.
Bailly C. Bailly C. Pharmacol Res. 2019 Oct;148:104398. doi: 10.1016/j.phrs.2019.104398. Epub 2019 Aug 12. Pharmacol Res. 2019. PMID: 31415916 Review.
Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Houot R, Bachy E, Cartron G, Gros FX, Morschhauser F, Oberic L, Gastinne T, Feugier P, Duléry R, Thieblemont C, Joris M, Jardin F, Choquet S, Casasnovas O, Brisou G, Cheminant M, Bay JO, Gutierrez FL, Menard C, Tarte K, Delfau MH, Portugues C, Itti E, Palard-Novello X, Blanc-Durand P, Al Tabaa Y, Bailly C, Laurent C, Lemonnier F. Houot R, et al. Among authors: bailly c. Nat Med. 2023 Oct;29(10):2593-2601. doi: 10.1038/s41591-023-02572-5. Epub 2023 Sep 14. Nat Med. 2023. PMID: 37710005 Free PMC article. Clinical Trial.
Etoposide: A rider on the cytokine storm.
Bailly C. Bailly C. Cytokine. 2023 Aug;168:156234. doi: 10.1016/j.cyto.2023.156234. Epub 2023 Jun 1. Cytokine. 2023. PMID: 37269699 Review.
Immuno-PET: Design options and clinical proof-of-concept.
Lugat A, Bailly C, Chérel M, Rousseau C, Kraeber-Bodéré F, Bodet-Milin C, Bourgeois M. Lugat A, et al. Among authors: bailly c. Front Med (Lausanne). 2022 Oct 14;9:1026083. doi: 10.3389/fmed.2022.1026083. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36314010 Free PMC article. Review.
Anticancer properties of lamellarins.
Bailly C. Bailly C. Mar Drugs. 2015 Feb 19;13(3):1105-23. doi: 10.3390/md13031105. Mar Drugs. 2015. PMID: 25706633 Free PMC article. Review.
Immuno-PET for Clinical Theranostic Approaches.
Bailly C, Cléry PF, Faivre-Chauvet A, Bourgeois M, Guérard F, Haddad F, Barbet J, Chérel M, Kraeber-Bodéré F, Carlier T, Bodet-Milin C. Bailly C, et al. Int J Mol Sci. 2016 Dec 28;18(1):57. doi: 10.3390/ijms18010057. Int J Mol Sci. 2016. PMID: 28036044 Free PMC article. Review.
Novel PD-L1-Targeted Phenyl-Pyrazolone Derivatives with Antioxidant Properties.
Regnault R, Klupsch F, El-Bouazzati H, Magnez R, Le Biannic R, Leleu-Chavain N, Ahouari H, Vezin H, Millet R, Goossens JF, Thuru X, Bailly C. Regnault R, et al. Among authors: bailly c. Molecules. 2023 Apr 15;28(8):3491. doi: 10.3390/molecules28083491. Molecules. 2023. PMID: 37110727 Free PMC article.
802 results